David John, PA-C

David John practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

David John's NPI, 1811226970, was assigned on December 18, 2009. David John graduated from University of Texas Southwestern Medical School at Dallas in 2008. David John holds Texas license PA05795.

David John's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

David John's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where David John practices. Vendor and product names are available with a free account.

Physician assistant is David John's primary specialty in the NPI Registry, under taxonomy code 363A00000X. David John is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). David John is licensed in Texas.

Dmand AI lists bladder disease, enlarged prostate and UTI among the conditions David John treats.

CMS data shows 173 Medicare services from David John across 2 procedure codes in 2024, for 160 Medicare patients. Medicare paid $7,315 for them.

CMS counts 160 Medicare patients who saw David John in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David John's median patient age at 70, with 11% women.

In 2024, David John wrote 343 Medicare Part D claims for 158 patients. 98% of them were for generic drugs. CMS names the drug for 260 of them, across 9 drugs with 11 or more claims each, at $3,707 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for David John for performance year 2024, reported as part of a group. David John accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists David John as offering telehealth.

Dmand AI links 2 papers to David John in 2007. 2007 was the busiest year, with 2. The most frequent topics are Diatoms, Phytoplankton and Ribulose-Bisphosphate Carboxylase.

CMS Open Payments shows 7 general payments to David John from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Exelixis Inc. paid the most, $51.

David John graduated from University of Texas Southwestern Medical School at Dallas in 2008.